Bernice Welles
Director/Board Member bei American Life Science Pharmaceutical, Inc.
Profil
Bernice R.
Welles is currently a Director at American Life Science Pharmaceutical, Inc., a Member at The Endocrine Society, and a Partner at IPF Management I SARL.
Previously, she worked as the Chief Executive Officer at Alquest Therapeutics, Inc. from 2010 to 2013, Vice President-Product Development at Genentech, Inc. from 1995 to 2003, Vice President-Development at DiObex, Inc. from 2005 to 2008, Chief Medical Officer at Enject, Inc. from 2009 to 2013, and as a Venture Partner at MPM BioImpact, Inc. from 2003 to 2005.
She also served as an Independent Director at Spectrum Pharmaceuticals, Inc. and as Treasurer & Director at The San Francisco Food Bank.
Dr. Welles is a graduate of Brandeis University, Tufts University, Albany Medical College, and The Wharton School of the University of Pennsylvania.
Aktive Positionen von Bernice Welles
| Unternehmen | Position | Beginn |
|---|---|---|
| The Endocrine Society | Corporate Officer/Principal | 01.12.2010 |
American Life Science Pharmaceutical, Inc.
 American Life Science Pharmaceutical, Inc. Pharmaceuticals: GenericHealth Technology American Life Science Pharmaceutical, Inc. engages in developing small molecule drugs for treating neurodegenerative disease. It initially focuses on TBI and Alzheimer''s disease. The company was founded by Gregory Hook and Vivian Hook in 2002 and is headquartered in La Jolla, CA. | Director/Board Member | - |
| IPF Management I SARL | Private Equity Investor | - |
Ehemalige bekannte Positionen von Bernice Welles
| Unternehmen | Position | Ende |
|---|---|---|
| Alquest Therapeutics, Inc. | Chief Executive Officer | 01.01.2013 |
Enject, Inc.
 Enject, Inc. Pharmaceuticals: MajorHealth Technology Enject, Inc. engaged in drug development. The company was founded in 2007 and was headquartered in Battle Ground, WA. | Chief Tech/Sci/R&D Officer | 01.12.2010 |
DiObex, Inc.
 DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01.01.2008 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01.04.2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31.07.2003 |
Ausbildung von Bernice Welles
| Brandeis University | Undergraduate Degree |
| Tufts University | Graduate Degree |
| Albany Medical College | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
DiObex, Inc.
DiObex, Inc. Pharmaceuticals: MajorHealth Technology DiObex, Inc. develops therapies for metabolic disease treatment. Its products address the markets for the treatment of diabetes and its co-morbidities such as hypertension, dyslipidemia, and visceral adiposity. The company was founded in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Enject, Inc.
Enject, Inc. Pharmaceuticals: MajorHealth Technology Enject, Inc. engaged in drug development. The company was founded in 2007 and was headquartered in Battle Ground, WA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
The San Francisco Food Bank
 The San Francisco Food Bank Services to the Health IndustryHealth Services The San Francisco Food Bank collects, sorts, inspects, repackages and distributes food. The company was founded in 1987 and is headquartered in San Francisco, CA. | Health Services |
| The Endocrine Society | |
American Life Science Pharmaceutical, Inc.
American Life Science Pharmaceutical, Inc. Pharmaceuticals: GenericHealth Technology American Life Science Pharmaceutical, Inc. engages in developing small molecule drugs for treating neurodegenerative disease. It initially focuses on TBI and Alzheimer''s disease. The company was founded by Gregory Hook and Vivian Hook in 2002 and is headquartered in La Jolla, CA. | Health Technology |
| IPF Management I SARL | Finance |
| Alquest Therapeutics, Inc. |
